Choreo LLC’s Cavium, Inc. CAVM Stock Holding History

Choreo LLC’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-18,488	Closed	-$18K	–	297
2017 Q1	$18K	Sell	18,488 -15,479	-46%	-$1.04M	﹤0.01%	280
2016 Q4	$34K	Buy	+33,967	New	+$1.96M	0.01%	254

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Choreo LLC's CAVM Position: Q2 2017 in Review

Choreo LLC sold out of Cavium, Inc. (CAVM) in Q2 2017, closing a stake of 18,488 shares — an estimated $18K sold.

Choreo LLC first reported a position in CAVM in Q4 2016 and held it in 2 quarters. The position peaked at $34K in Q4 2016. 250 funds tracked by Wall St. Rank hold CAVM as of Q2 2017.

Choreo LLC reported no remaining Cavium, Inc. position as of Q2 2017 after selling out during the quarter.
Choreo LLC sold 18,488 Cavium, Inc. shares in Q2 2017, an estimated $18K.
Choreo LLC first reported a position in Cavium, Inc. in Q4 2016 and held it in 2 quarters.
Choreo LLC's Cavium, Inc. position peaked at $34K in Q4 2016.
250 funds tracked by Wall St. Rank held Cavium, Inc. as of Q2 2017.

Based on Choreo LLC's 13F filing for Q2 2017, filed 4 Jun 2020.